We detected a novel susceptibility gene, SLER1, for systemic lupus erythematosus (SLE) at 5p15.3.
Introduction
Systemic lupus erythematosus (SLE) [MIM 152700 ] is a complex disease in which immune responses are directed against a multitude of self-antigens. Both environmental and genetic factors are involved in the pathogenesis. Substantial evidence has shown that SLE clusters in families with a 7-12% increased risk among the first-or second-degree relatives of a proband, 2 an increased concordance rate in identical twins (15-69%) as opposed to dizygotic twins (2-5%) 3 and genome scans showing moderate support for genetic linkages. The relative risk ratio for the siblings of an affected proband (l s ) varies from 20 to 40. 4 Significant gender differences are observed in prevalence, age at onset, premorbid conditions, clinical expression, course of illness, response to treatment and morbid risk. In addition, there are important racial differences in disease manifestations. Multiple genome scans and collaborative efforts have identified evidence for linkage on several chromosomes, [5] [6] [7] [8] [9] [10] [11] [12] which clearly demonstrate that SLE is a complex and heterogeneous genetic disease.
Complex genetic phenotypes are usually characterized by multiple loci with multiple susceptibility alleles that apparently have low penetrances and are common in the general population, with no particular allele being necessary or sufficient for clinical disease. 13, 14 This characteristic makes their identification difficult, requiring very large numbers of multiplex families for linkage analysis. Various combinations of contributing alleles at multiple genes in individual patients may give the appearance of disease phenocopies. Clinical heterogeneity of the disease may also arise from different genotypephenotype interactions or from population heterogeneity. Consequently, the detection of genetic effects of such diseases requires large numbers of carefully characterized families.
SLE cosegregates with other autoimmune diseases like rheumatoid arthritis (RA), Sjogren's syndrome and the antiphospholipid antibody syndrome in families. Between 10 and 20% of SLE probands of most studies have at least one first-or second-degree relative afflicted with other autoimmune diseases. In a classic study, Bias et al 15 defined an 'autoimmune phenotype' in SLE pedigrees based on the presence of an autoimmune disease and/or autoantibodies (eg, rheumatoid factors (RF), anti-smooth muscle antibodies, anti-acetylcholine-esterase antibodies, thyroid insufficiency). The most parsimonious model for the mode of inheritance of this new phenotype was autosomal dominant inheritance with variable penetrance (women 92% and men 49%). They proposed a gene that confers susceptibility to autoimmunity, while other genes (such as those in the HLA, T-cell receptors or immunoglobulin allotypes) bestow specificity to the autoimmune phenotype developed.
Leal and Ott 16 demonstrated that stratification by clinical symptoms may increase power to detect linkage when phenotypic heterogeneity is the result of genetic heterogeneity. In our previous study, 1 we performed a genome-wide linkage screen on a set of 36 SLE families, multiplex for both SLE and self-reported or 'alleged rheumatoid arthritis' (SLE-ARA). We used the number of alleged RA diagnoses in pedigrees as a measure of the tendency for polyarthritis in the pedigree and not as an indication of the relationship of RA to SLE. All the SLE patients met the 1997 revised criteria for diagnosis of SLE, 17, 18 while alleged RA status was determined by selfreport or diagnosis by a physician in the medical record. For linkage analyses, only those individuals affected with SLE were considered as affected. Therefore, the study phenotype was SLE. This was consistent throughout the original and replication samples. The most significant evidence of linkage to SLE was obtained at 5p15.3 on the marker D5S2505 by both nonparametric (Zlr ¼ 5.65, P ¼ 8.0 Â 10
À9
) and parametric (LOD ¼ 6.2, HLOD ¼ 6.3, a ¼ 0.95) analysis methods for 14 SLE-ARA families from a European-American (EA) ethnic background. The best-fitting model for this putative SLE susceptibility locus in this region was a recessive gene with a population frequency of 5%, and with 50% penetrance in females and 15% penetrance in males.
Replication of previous linkage signals from independent data set is an important and essential first step for establishing and confirming linkages. Since we previously detected the SLE susceptibility locus at this region, our a priori hypothesis of linkage was fixed at 5p15.3. In this situation, to confirm the initial linkage signal, the significance of linkage would be declared for Zlr score greater than 2.3 (equivalent to a P-value of 0.01 and LOD score 1.17). 19, 20 The main objective of this study was to replicate and confirm the linkage at 5p15.3 based on an independent data set of 88 such SLE-ARA families.
Results

SLE-ARA families
In these 88 SLE-ARA families, there were 203 individuals affected with SLE and 214 individuals with alleged RA. There are 137 affected SLE individuals (67%) who also had a medical history of having been diagnosed with rheumatoid arthritis. Indeed, the small joint polyarthritis and synovitis of SLE can be very similar in its clinical presentation to archetypical RA, often even with a positive rheumatoid factor. We postulated that in these ascertained families, the gene predisposing to SLE may also lead clinicians to conclude (falsely or not) that RA was present. If the tendency of families to contain individuals with polyarthritis has a genetic origin, then the decreased genetic heterogeneity may improve power to detect the related SLE susceptibility gene(s). If this is the case, then arthritis-related clinical features should be concentrated in the SLE patients from SLE-ARA families compared to the SLE patients from SLE-only families.
We randomly selected one SLE patient from each pedigree from SLE-ARA as well as from SLE-only families to control for the intrafamilial correlation among family members. These SLE patients do show the predicted associations (Table 1 ). The presence of symmetrical arthritis and positive (titer 41:20 by latex IgM) RF were significantly increased in the SLE patients from SLE-ARA families compared with SLE patients from SLE-only families. Other serological manifestations (antiRo, anti-La, and anti-nRNP) were similar between the two groups of SLE patients (P40.05).
Replication of linkage at 5p15.3
The genetic model (mode of inheritance, disease-allele frequency and penetrances of genotypes at the disease locus) at 5p15. 3 is not yet established, and this is especially so when families from multiple ethnic backgrounds are considered together, as in the present replication study. Consequently, it is highly likely to find that the model used previously failed to provide additional evidence for linkage. We therefore sought to confirm linkage at 5p13.3 by using a nonparametric allele-sharing method in these 88 SLE-ARA families. The results of nonparametric linkage analysis of all 88 SLE-ARA families (Table 2) show that the maximum twopoint (Zlr ¼ 2.50, P ¼ 6.2 Â 10 À3 ) and multipoint (Zlr ¼ 2.58, P ¼ 4.9 Â 10 À3 ) nonparametric linkage scores (Zlr) were found at 19 cM on D5S807 and at 22.2 cM between D5S807-D5S817, respectively, from the p-terminal. The corresponding nonparametric LOD scores 21 were 1.36 and 1.45, respectively.
In our previous study, 1 we found the peak linkage at D5S2505, which is approximately 8.2 cM away from the current peak ( Figure 1 ). The Zlr score at this marker (D5S2505) in the replication sample is 2.3 (P ¼ 0.01, LOD ¼ 1.15). The peaks of the original and replication studies are different, but they are close to each other. Moreover, at the LOD for the replication set of pedigrees, the effect in the original set of pedigrees is LOD 46, Confirmation of SLER1 at 5p15.3 SK Nath et al which remains sufficiently impressive to establish linkage. To test the relationship of linkage to ethnicity, we also performed a separate race-specific linkage analysis for pedigrees from the European-Americans (n ¼ 30), African-Americans (n ¼ 42) and Hispanics with others (n ¼ 16). Race-specific marker allele frequencies were estimated from the unrelated individuals for the respective ethnic groups. The major contribution for linkage was found in the African-Americans (Zlr ¼ 2.83, P ¼ 0.002, LOD ¼ 1.74), while the others made smaller contributions, European-American (Zlr ¼ 0.45, P ¼ 0.3, LOD ¼ 0.04), and Hispanic with others (Zlr ¼ 0.84,
To test the hypothesis that high incidence of RA in the SLE families would be more genetically homogeneous at the 5p15.3 SLE susceptibility locus, we measured the correlation between identity-by-descent allele sharing and alleged RA incidence in the family. We used the correlation between family-specific nonparametric linkage (NPL) score and number of alleged RA in the families. We observed a significant correlation (Spearman's r ¼ 0.22, Po0.03) between NPL score and alleged RA incidence in the family, which also provided statistical evidence supporting the hypothesis that pedigrees with higher density alleged RA (three or more individuals with RA per family) would be more genetically homogeneous and would concentrate the genetic disposition for polyarthritis that was being grossly measured.
Of the 88 SLE-ARA families, 30 had three or more individuals with RA (18 African-American, seven European-American, four Hispanic and one Native-American). Two-and multipoint analyses, weighted on the presence of three or more relatives with a common ancestor in the pedigree with RA, demonstrated the increase of the linkage evidence ( Table 1 ). The Zlr scores increased to 3.01 and 3.32 in two-and multipoint analyses, respectively, and the LOD per pedigree dramatically increased from 0.015 and 0.016 to 0.066 and 0.08, respectively.
Finally, a permutation procedure was used to assess the significance of the increase in the Zlr score at the peak position. In all, 10 0000 replicates of a simulation in which 30 families were randomly chosen from the 88 families to generate P-value at the peak position. Pvalues exceeding the observed Zlr scores at the peak position evidenced by two-and multipoint analyses occurred with probability 0.0131 and 8.2 Â 10 À3 . To evaluate the previously described best-fitted parametric genetic model 1 in the newly ascertained pedigrees, we performed the parametric linkage analysis using that disease allele frequency and penetrance functions for the genotypes at the disease locus ( Table 3 ). The strongest evidence for linkage was found at or near D5S807 based on two-point and multipoint analyses, whereas, minimal evidence of linkage for all of the 88 SLE-ARA families by both two-point (HLOD ¼ 0.6, Empirical P-value is based on 10 000 replicates. 
SLE-
Discussion
Many of the genes that predispose to SLE must undoubtedly also be related to key events in pathogenesis of other autoimmune diseases. If such genes are also involved in certain manifestations of SLE as well as RA, then linkage analysis based on only the SLE families that also contain SLE individuals with a relevant clinical covariate like RA has the potential to improve greatly the power to detect the susceptibility loci for SLE. We used the number of family members with alleged RA as a measure of the tendency for polyarthritis in families multiplex for SLE. Not surprisingly, SLE and alleged RA were significantly associated, especially in the SLE-ARA families. We have postulated that it is possible that SLE and alleged RA (or the tendency for polyarthritis) may share some common autoimmune genetic determinant(s). Genes shared between RA and SLE are also possible, since there is a tendency to find RA and SLE in the same pedigree. 22, 23 Becker et al. 24 compared linkage results from 23 autoimmune or inflammatory disease studies and identified clustering of mapped candidate autoimmune loci to 18 genomic regions, supporting the hypothesis of a possible partially shared genetic basis for some forms of autoimmunity.
Replication of initial linkage signals from independent samples is the crucial application of the scientific method that allows one to distinguish apparent true positives from indeterminate and false-positive results. 19 Replication of linkage results for complex traits has been exceedingly difficult, owing in part to the inability to measure the precise underlying phenotype, small sample sizes, genetic heterogeneities, inaccurate genetic models and statistical methods employed in the analyses. 25 In their paper, Lander and Kruglyak suggested the term 'replication study' should be reserved in which significant evidence of linkage has already been obtained in an initial study. The reported linkage to SLE at 5p15.3 1 satisfies this criterion.
The highly significant linkage to SLE with the SLE-ARA was found in European-American families, 1 although linkage in remaining 19 African-American families used in the previous analysis could not be excluded (LOD ¼ 0.77). In the present study, the strongest evidence for linkage in this region came from the African-American SLE-ARA families. This result suggests that the genetic effect is present in both racial groups and that the magnitude of the effect may be more similar than previously suspected.
For a replication study, one would expect to use the similar analysis methods as the original study. In our original study, we used six screening models to search the entire genome and found the linkage at 5p15.3. Once the linkage was detected, we decided to optimize the genetic model by maximizing the LOD score. This was how the final genetic model for the European-American families at 5p15.3 was determined. Simultaneously, we also performed the nonparametric linkage analysis. However, the present study was a replication study and our a priori hypothesis was set at 5p13.3. All the genome screening models previously reported 1 were not performed in this group of 88 additional SLE-ARA pedigrees. We only tested the best-fitted genetic model from the previous study, consequently, no correction for multiple testing was made.
Since the present replication sample consisted of three major ethnic groups, it is highly unlikely that the final model from our previous study would be appropriate model for all ethnic groups or all SLE-ARA families together. So, to find the evidence of linkage at 5p15.3, and replicate the evidence of linkage at 5p15.3, we decided to apply nonparametric model independent linkage analysis. Another advantage of using the non parametric method is that it is very robust particularly for a complex disease like SLE. The nonparametric approach is useful in this situation because the particular details of the model are much less relevant.
Using the best-fitted parametric genetic model, the estimated proportion of the linked families using the entire replication collection (Table 3 ) of 88 SLE-ARA families is relatively low (24-31%). A substantial increase of linkage was evidenced in 30 SLE-ARA families, where three or more individuals also had alleged RA compared to all 88 SLE-ARA families. If this were due to the 'loading' of RA, then we would expect an equal proportion of linked families (a) in all the ethic groups in the race-specific analysis. On the other hand, if this were due to ethnic heterogeneity, then we would expect a to be large in one ethnic group. While the overall multipoint parametric linkage analysis under heterogeneity (HLOD) for 88 SLE-ARE families were 0.8, then the 30 families with three or more RA was 2.83 with same genetic model. Interestingly, the evidence of linkage came from all three groups of families with different ethnic origins. Therefore, the linkage results at 5p15.3 clearly indicate that stratification of families based on three or more individuals with alleged RA are more homogeneous regardless of their ethnic origin.
Recently, evidence from a genome scan of 526 multiplex RA families 26 found modest evidence of linkage to a RA susceptibility gene with markers D5S807 and D5S817 (P-value o0.05). This is in the same genetic location as markers that are linked in our SLE-ARA data sets. When considered with our results, this observation supports there being a susceptibility gene in both the phenotypes of SLE and RA at 5p15.3.
The outcome of this experiment is provocative and has led to a search for possible candidate genes that are related to apoptosis in the 5p15.3 linkage interval. The apoptotic cells are thought to be fundamental to the initial trigger and development of autoimmunity. Defective cells in activation-induced cell death can cause autoimmunity by allowing the survival of autoreactive T and B cells. They include DAP (death-associated protein) and PDCD6 (programmed cell death 6), a proline-rich, 15-kDa protein thought to mediate programmed cell death induced by interferon-g. 27 Other interesting candidate genes in 5p15.3 include telomerase reverse transcriptase (TERT, EST2), which is the enzyme essential for completing the replication of the terminal DNA of most eukaryotic chromosomes. Human TERT is the catalytic subunit and a key factor in controlling telomerase activity. The activation of telomerase is well known to be associated not only with carcinogenesis but also with apoptosis. Also, the Ro autoantigen appears to be associated with the telomerease complex. 28 Recently, both synovial proliferation in RA 29 and increased disease activity in SLE 30 have been shown to be associated with increased telomerase activity. The availability of the genome sequence and accompanying dense SNP map will facilitate identifying the putative susceptibility gene.
In summary, our new results from an independent set of multiplex SLE-ARA families have confirmed our initial linkage signal. 19, 20 Clearly, the SLER1 linkage at 5p15.3 for SLE is convincing when evaluated in pedigrees multiplex for SLE and for alleged RA. This result clearly demonstrates that carefully identified subgroup analysis may be extremely powerful for identifying the susceptibility gene(s) for complex (heterogeneous) diseases like SLE. To the best of our knowledge, this is one of the few confirmed SLE linkage results to date. The results of previous findings, together with our new results, have provided strong evidence that SLER1 at 5p15.3 is a susceptibility gene for SLE, especially in the SLE families with multiple cases of alleged RA. The confirmation of linkage to 5p15.3 strongly encourages efforts to identify the responsible SLE susceptibility gene.
Materials and methods
Ascertainment of SLE-ARA families
Detailed procedures for recruitment of families have been described elsewhere. 5, 10 In brief, SLE status was determined in accordance with the revised American College of Rheumatology (ACR) criteria. 17, 18 The presence of alleged RA status was determined by self-report or diagnosis by a physician in the medical record (Dr Namjou carefully evaluated all of the medical records). In an effort to replicate and confirm our initial linkage at 5p15.3, we ascertained 88 families, not included in the initial linkage, which were selected with the same ascertainment criteria (Z2 SLE affecteds and Z2 alleged RA related family members (termed as SLE-ARA), as described in Namjou et al 1 ). Of these 88 SLE-ARA pedigrees, 30 (34%) were European-American, 42 (48%) were African-American, 13 (15%) were Hispanic and three (3%) were Native-American.
Genotyping and error checking Genomic DNA was isolated from peripheral blood cells, buccal cell swabs, mouth wash specimens or EBVtransformed cell lines using standard methods. Genotyping methods are described elsewhere. 5, 10 Six STR markers from the linked region (5p15.3) were genotyped. Marker map positions were obtained from the latest available sex-averaged maps from the Marshfield database. The six markers used in the present study along with their corresponding intermarker distances (cM) are as follows: D5S2488-9.4-D5S2088-4.8-D5S2505-2.5-D5S1953-2.3-D5S807-4.0-D5S817. Prior to linkage analysis, all family relationships were confirmed using RELTEST. 31 Statistical analysis Two-point and multipoint nonparametric linkage analyses were carried out by means of the 'S pairs ' scoring function and exponential likelihood-based allele-sharing model implemented in GENEHUNTER-PLUS, 21 which is a modification of the GENEHUNTER 32 package. Results were reported in terms of the Zlr statistic, the LOD score (LOD ¼ Zlr 2 /2 ln 10) and its associated one-sided Pvalue. Under the null hypothesis of no linkage, the Zlr statistic is distributed asymptotically as a standard normal random variable. The nonparametric LOD score based on allele sharing can be used within the same inferential framework as the traditional LOD score. 21 Estimates of allele sharing were based on the markerallele frequencies estimated from the pedigree founders for each ethnic group. Linkage results were very similar, whether the marker allele frequencies were estimated from each ethnic group or from the overall sample. Parametric linkage in the presence of heterogeneity was assessed using heterogeneity LOD (HLOD) scores. HLOD scores and their accompanying estimates of the percentage of linked families (a) were calculated using the statistical software package GENEHUNTER-PLUS. 21, 32 A permutation procedure was conducted to assess the significance of the increase in the Zlr score at the peak position, especially when a subgroup analysis was conducted.
